Rocket One Inc.
Business
Rocket One Inc. is a clinical-stage biopharmaceutical company developing therapies for cancer, allergic diseases, neuroinflammatory conditions, and obesity. The company's pipeline includes HT-001 (topical for EGFR-inhibitor skin toxicity, in Phase 2a), HT-KIT (for mast cell cancers and anaphylaxis, in preclinical/IND-enabling), HT-ALZ (Alzheimer's and neuroinflammation, in formulation development), BioLexa (eczema, completed Phase 1b), HT-004 (asthma/allergies, preclinical), and HT-VA (obesity, in preclinical proof-of-concept). The company licenses intellectual property from academic institutions and government agencies, outsources manufacturing, and intends to pursue commercialization through third-party partners upon regulatory approval.
Summary from 10-K filed 2026-03-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| NET REVENUES | — | — | — | — | — | |
| Research and development expenses | 6 | 3 | 4 | 5 | 7 | |
| General and administrative expenses | 6 | 5 | 4 | 6 | — | |
| Total operating expenses | 12 | 8 | 8 | 11 | 14 | |
| LOSS FROM OPERATIONS | −12 | −8 | −8 | −11 | −14 | |
| Change in fair value of investment in joint venture | — | −581 | 4,400 | — | — | |
| Unrealized loss on crypto assets | −108,633 | — | — | — | — | |
| Dividend and interest income | 680 | 27,713 | 51,772 | — | — | |
| Total other (expenses) income, net | −107,953 | 27,132 | −153,148 | −306,399 | −212,265 | |
| NET LOSS | −12 | −8 | −8 | −11 | −14 | |
| Basic (per share) | −0.9 | −1.28 | −2.38 | −9.5 | −16.02 | |
| Diluted (per share) | −0.9 | −1.28 | −2.38 | −9.5 | −16.02 | |
| Basic (shares) | 14 | 6 | 3 | 1 | 893,226 | |
| Diluted (shares) | 14 | 6 | 3 | 1 | 893,226 | |
| Foreign currency translation adjustment | 1,768 | −18,197 | 5,254 | 4,420 | 32,937 | |
| Total comprehensive loss | −12 | −8 | −8 | −11 | −14 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2024 2024-09-30 | FY 2024 2024-06-30 | FY 2024 2024-03-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 6 | 7 | — | — | — | |
| Prepaid expenses and other current assets | 366,548 | 605,948 | 656,386 | 839,037 | 910,179 | |
| Crypto assets, at fair value | 191,367 | — | — | — | — | |
| Deferred offering costs | 57,171 | — | — | — | — | |
| Total Current Assets | 7 | 8 | 9 | 10 | 9 | |
| Prepaid expenses and other assets, net of current portion | 699,420 | — | — | — | — | |
| Operating lease right-of-use asset, net | 4,652 | 31,075 | — | — | — | |
| Investment in joint ventures at fair value | 36,819 | 36,819 | — | — | — | |
| Total Non-Current Assets | 740,891 | 67,894 | — | — | — | |
| Total Assets | 8 | 8 | 9 | 11 | 9 | |
| Accounts payable | 823,674 | 412,071 | — | — | — | |
| Accrued expenses | 623,323 | 390,760 | — | — | — | |
| Operating lease liability, current portion | 5,678 | 28,366 | — | — | — | |
| Total Current Liabilities | 1 | 831,197 | — | — | — | |
| Operating lease liability, less current portion | — | 2,709 | — | — | — | |
| Total Long-Term Liabilities | — | 2,709 | — | — | — | |
| Total Liabilities | 1 | 833,906 | — | — | — | |
| Commitments and Contingencies (Note 6) | — | — | — | — | — | |
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 3,000,000 shares undesignated; 0 shares issued and outstanding as of December 31, 2025 and 2024 | — | — | — | — | — | |
| Common stock, $0.0001 par value; 50,000,000 shares authorized; 15,514,312 and 8,042,747 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 1,551 | 850,500 | — | — | — | |
| Additional paid-in capital | 79 | 67 | — | — | — | |
| Accumulated deficit | −73 | −60 | −58 | −56 | −54 | |
| Accumulated other comprehensive income | 10,831 | 9,063 | — | — | — | |
| Total Stockholders Equity | 6 | 7 | 8 | 10 | 8 | |
| Total Liabilities and Stockholders Equity | 8 | 8 | 9 | 11 | 9 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Research and development-acquired patent, expensed | 850,500 | — | −275,000 | — | — | |
| Stock-based compensation | 1 | 804,277 | 216,428 | 620,798 | 1 | |
| Stock-based professional fees | 333,150 | — | — | — | — | |
| Lease costs | 1,026 | — | — | — | — | |
| Unrealized loss of crypto assets | 108,633 | — | — | — | — | |
| Prepaid expenses and other current assets | −460,020 | 252,178 | 213,432 | 3,847 | −5,420 | |
| Accounts payable and accrued expenses | 644,166 | 153,013 | −700,752 | — | — | |
| NET CASH USED IN OPERATING ACTIVITIES | −10 | −7 | −8 | −9 | −12 | |
| Purchase of crypto assets | −300,000 | — | — | — | — | |
| NET CASH USED IN INVESTING ACTIVITIES | −300,000 | — | — | 1 | −165,355 | |
| Proceeds from issuance common stock, net of offering costs | 4 | — | 11 | 6 | 4 | |
| Proceeds from issuance of common stock, common stock warrants and prefunded warrants, net of offering costs | — | 1 | — | — | — | |
| Proceeds from exercise of warrants | 6 | 4 | 2,355 | — | 359,513 | |
| Taxes paid related to net share settlement of equity award | −376,000 | — | — | — | — | |
| Payment of deferred offering costs | −57,171 | — | — | — | — | |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 9 | 5 | 11 | 6 | 18 | |
| NET DECREASE IN CASH AND CASH EQUIVALENTS | −793,224 | −2 | 3 | −2 | — | |
| Effect of exchange rate changes on cash and cash equivalents | 1,768 | −18,197 | −6,518 | −9,593 | −30,562 | |
| Increase in prepaid expenses and other current assets and additional paid-in capital related to issuance of warrants for future services | 333,150 | — | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Rocket One Inc.'s CIK number?
Rocket One Inc.'s SEC CIK number is 0001711786 (1711786). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Rocket One Inc.'s SEC filings?
All of Rocket One Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.